Hosted on MSN
New group of potential diabetes drugs with fewer side effects can reprogram insulin-resistant cells to be healthier
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results